Hydration Pharmaceuticals Co. Ltd. (AU:HPC) has released an update.
Hydration Pharmaceuticals Co. Ltd. has reported a strong second quarter with a record gross profit of $1.5m for the second time, a 52% decrease in adjusted EBITDA loss, and a 24% increase in net sales from the previous quarter. The company successfully reduced marketing costs and operating expenses, improving cash reserves and profitability margins. This positive financial performance is underpinned by robust growth in Canadian ecommerce operations and the addition of a new medical supply customer in the US.
For further insights into AU:HPC stock, check out TipRanks’ Stock Analysis page.